Intent of Legislation: To promote drug-free workplaces in order that employers in Georgia are afforded the opportunity to maximize their levels of productivity, enhance their competitive positions in the marketplace and reach their desired levels of success, without experiencing the costs, delays, and tragedies associated with work-related accidents resulting from substance abuse by employees. (OCGA 34-9-410)

Directions: Please complete the application and submit with the $35.00 fee. The State Board of Workers’ Compensation will review this application and determine whether all the criteria for certification have been met. The State Board of Workers’ Compensation then either will document your drug-free workplace program status by issuing certification or in the event that all criteria have not been met, the State Board of Workers’ Compensation will require additional information or action.

Documentation of certified Drug-Free Workplace Program: For purposes of documenting your certified drug-free workplace program, it is necessary to maintain your policy and the records required by this application in a separate file for review by your insurer or the Georgia State Board upon request.

Notification to insurer: An insured employer must notify his/her insurer in writing of such certification. When notifying insurer, the employer should enclose a copy of the certificate issued by the State Board of Workers’ Compensation documenting a certified drug-free workplace. (OCGA 33-9-40.2(a)) This notification to insurer must occur annually!

When does the premium credit begin to accrue? The premium discount will be applied pro rata as of the date of certification (the date of approval by the Georgia State Board of Workers’ Compensation).

When does the insured actually receive payment for the credit? The insured employer, however, will not receive payment for such credit until after the annual final premium audit under such policy. (OCGA 33-9-40.2 (b))

How long will an insured employer receive the 7.5% discount? The insured employer is entitled to receive the 7.5% premium credit for as long as the insured maintains the certification as having a drug-free workplace; provided, however, an insurer shall not be required to credit the actual amount of the premium discount to the account of the insured until the final premium audit under such policy. (OCGA 33-9-402 (b))

***Annual certification required – An employer must be certified annually and must maintain his/her certified drug-free workplace program during each year the employer receives the discount.***

The following information and checklist should be used as the rules and guidelines to assist you in implementing a certified drug-free workplace program.

In accordance with the definition of employer in this law, the state or any department, agency, or instrumentality of the state; county or independent school systems; counties or municipal corporations may not apply or qualify for the 7.5% discount. Definitions applicable to the law and to this document have been attached. (OCGA 34-9-411)

If an employer implements a drug-free workplace program substantially in accordance with this checklist, the employer shall qualify for certification for a 7.5 % premium discount under such employer’s workers’ compensation insurance policy. (OCGA 34-9-412 through 34-9-421)

If an employer misrepresents compliance, however, with its certified drug-free workplace program, the employer shall be subject to an additional premium for purposes of reimbursement of a previously granted discount AND to cancellation of the policy. (OCGA 33-9-40.2 (c))

If an employer has made a good-faith effort to fulfill certain criteria for certification, however, this good-faith effort will be taken into consideration when determining whether he or she has complied substantially with certification criteria.

Remember, this law does not require drug-free testing, other forms of testing, or other actions presently allowed under existing law. (OCGA 34-9-415 (a))

Nor does the law preclude random testing, other forms of testing, or other actions presently allowed under existing law. (OCGA 34-9-415 (c))

Also included in this form are examples that should be helpful in explaining the certification requirements.

1-a. Elements of a Drug-Free Workplace Program: (OCGA 34-9-413)

1-b. Policy State Required for Certification: (OCGA 34-9-414(a)(1))

____________A statement of required types of substance abuse testing: (OCGA 34-9-414(a)(1)(A))

(For example, to the policy statement in the Drugs Don’t Work booklet, add [1] the ‘General Procedures’ paragraph on page 5, [2] the following specific types of drug testing also included in the Drugs Don’t Work booklet, and [3] one of the paragraphs on page 7, regarding alcohol testing.)

1. Job Applicant Testing Required for Certification: (OCGA 34-9-415(b))
(For example, add paragraph 1 on page 6 of the Drugs Don’t Work booklet.)

2. Reasonable Suspicion Testing Required for Certification: (OCGA 34-9-415(b))
(For example, see attached definition of reasonable suspicion and combine with paragraph 2, section 1 on page 6 of the Drugs Don’t Work booklet.)

3. Post Accident Testing Required for Certification: (OCGA 34-9-415 (b))
(For example, add the following as section 2 of paragraphs 2 on page 6 of the Drugs Don’t Work booklet:

4. Post Rehabilitation Testing Required for Certification:
(OCGA 34-9- 415 (b))
(For example, add paragraph 2, section 3 on page 6 of Drugs Don’t Work booklet.)

5. Routine-Fitness-for-Duty Testing Required for Certification:
(OCGA 34-9-415 (b))
(For example, add the following as section 4 of paragraph 2 on page 6:

____________A statement of actions employer may take against employee or job applicant on the basis of a positive confirmed test result:
(OCGA 34-9-414 (1) (B))

____________A statement of consequences of an employee's or job applicant's refusal tosubmit to a drug test: (OCGA 34-9-414 (4))

____________A statement advising employee or job applicant of the existence of the article outlining a certified drug-free workplace program: (OCGA 34-9-414 (2))
(For example: "The [COMPANY NAME] drug-free workplace program is certified by the Georgia Workers' Compensation Board in accordance with Title 34, Chapter 9, Article 11 of the Official Code of Georgia Annotated.")

____________A general confidentiality statement: (OCGA 34-9-414 (3))
(For example; "The confidentiality of any information received by the employer through a substance abuse testing program shall be maintained, except as otherwise provided by the law.")

____________EITHER a statement advising employee of Employee Assistance Program(EAP), if employer offers one:
OR
A statement advising employee of employer's resource file of assistance programs and other persons, entities, or organizations designed to assist employees with personal or behavior problems: (OCGA 34-9-414 (5))
(For example, see page 4 of the Drugs Don’t Work booklet.)

____________A statement advising employee or job applicant who receives a positive confirmed test result that he or she may contest or explain the result to the employer within five (5) working days after written notification of the test result: (OCGA 34-9-414 (6))
(For example, after the job applicant and employee testing paragraphs on page 6 of the Drugs Don’t Work booklet, add "Employees and job applicants who have a positive confirmed test result may explain or contest the result to the employer within five working days, after the employer contacts the employee and shows him or her the positive test result as it was received from the laboratory in writing.")

____________A statement informing an employee or job applicant of the federal Drug-Free Workplace Act, if it applies to you. (OCGA 34-9-414 (7))
(For example, see page 3 of the Drugs Don’t Work booklet and add the statement in the shaded blue box.)

1-c. Notice of Drug-Free Workplace Program Required for Certification:
(OCGA 34-9-414 (b) and (c))

____________EITHER 60 days' notice was given prior to implementation of testing.
OR
60 days' notice was not required because implementation of program occurred prior to July 1, 1993. (OCGA 34-9-414 (b))

____________Notice of substance abuse testing is included on vacancy announcements for positions in which testing is required. (OCGA 34-9-414 (c))

____________Notice of substance abuse testing is posted in an appropriate and conspicuous location on employer's premises. (OCGA 34-9-414 (c))

____________Copies of policy are available to employees and job applicants in employer's personnel office or other suitable location. (OCGA 34-9-414 (c))

2. Substance Abuse Testing Required for Certification: (OCGA 34-9-415 (b))

____________Job Applicant Testing Required for Certification: (OCGA 34-9-415 (b))

[1] Sensitive positions from a safety, health or security standpoint versus all other job applicants for non-sensitive positions.

[2] Full time positions versus part time positions.

[3] Positions in which the employer is responsible for wages and/ or benefits versus positions in which a temporary agency or employee leasing agency is responsible for wages and benefits.

[4] Other reasonable classifications of job positions.

____________Reasonable Suspicion Testing Required for Certification:
(OCGA 34-9-415 (b))

____________Post-Accident Testing Required for Certification: (OCGA 34-9-415 (b))

____________Post-Rehabilitation Testing Required for Certification: (OCGA 34-9-415 (b))

____________Routine-Fitness-for-Duty Testing Required for Certification: (OCGA 34-9-415 (b))

Regarding when to test for drugs, alcohol, or both:

2-b. Procedures for Substance Abuse Testing Required for Certification. (OCGA 34-9-415 (d) and (e))

Specimen Collection Responsibilities Required for Certification: (OCGA 34-9-415 (d) (1) through (5))

____________Collection of job applicant and employee specimen are performed in accordance with the following standards and procedures:

Standards for Specimen Collection:

• Specimen collection should be conducted in a manner reasonably to protect the privacy of the individual and to prevent substitution or contamination of the specimen.
• Specimen collection should be documented by labeling the containers to prevent erroneous identification of results.
• Specimen collection, storage, and transportation to the testing site should be performed in a manner which reasonably will preclude specimen contamination or adulteration.

Procedures for Specimen Collection:

Chain of custody procedures required:

• Chain of custody procedures must be used by the above individuals to ensure proper record keeping, handling, labeling, and identification of all specimens to be tested.

NOTE: NIDA/HHS (SAMHSA) and CAP laboratories provide the specimen collection packages that include the appropriate forms necessary for chain of custody procedures. These laboratories also may be able to provide training on proper collection procedures.

NOTE: Proper collection methods are essential in assuring accuracy of test results. As a result, if a specimen is not collected in accordance with the standards as set forth by NIDA/HHS (SAMHSA) and CAP laboratories, these laboratories will not accept the specimen for analysis.

Procedures regarding prescription and nonprescription medication:

NOTE: Though not required for certification, employers are STRONGLY encouraged to use the services of a Medical Review Officer (MRO) in determining the validity of a laboratory confirmed drug test result.

If a drug test result is confirmed positive, it is the employer’s responsibility to ensure prescription medications, over the counter drugs, or other medical history pertinent to the drug screen could affect the final result of the test.

If the employer does not wish to hire an MRO, the employer may ask the job applicant or employee for evidence of a prescription that may have affected the test result. In addition, NIDA/HHS (SAMHSA) and CAP labs offer technical assistance and MROs to interpret the results.

IMPORTANT NOTE: The employer should be mindful of the American’s with Disabilities Act (ADA) and pertinent liability issues in making the determination in the use of an MRO as part of a comprehensive drug-free workplace program.

A list of prescription and over the counter drugs that may affect test results is attached for your information. This list is included as an educational tool and is NOT exhaustive. In cases where drugs not included on this list appear in a test result, an employer may wish to consult the laboratory, an MRO, a pharmacist, or other expert on the effect that prescription and over the counter drugs have on laboratory test results.

Laboratories that must test specimens:

• NIDT devices (On-Site Kits) may be used for the initial screening for POST OFFER (or new hire) testing ONLY.
• For current employees, (Reasonable Suspicion, Post Accident, Post Rehabilitation, Fit-For-Duty), ALL specimens, initial and confirmation testing, must be tested only by a NIDA/HHS (SAMHSA) or CAP laboratory. (Also attached is information on how to find NIDA/HHS (SAMHSA) and CAP laboratories in Georgia .)
• All non-negatives from initial screening in Post Offer (New Hire) drug testing must be confirmed by GC/MS method in a NIDA/HHS (SAMHSA) or CAP laboratory.

Employer Responsibilities Required for Certification: (OCGA 34-9-415 (d) (6) through (12))

____________I am complying with the following procedures that are necessary for certification:

Notification of positive confirmed test results:

• Within 5 days after receipt of a positive confirmed test result from the laboratory, an employer must inform in writing a job applicant or employee the [1] fact that he or she tested positive, [2] the consequences of testing positive, and [3] the options available to the job applicant or employee.
• If the job applicant or employee requests, the employer shall provide a copy of the test results.
• An employer must ensure that all initial tests having a positive result are verified by a confirmation test.

If an employer has been trained to collect specimens:

• If an employer has been trained to collect specimens, the employer must use chain of custody procedures to ensure proper record keeping, handling, labeling, and identification of all specimens to be tested.

Payment for the initial and confirmation tests required by the employer:

• An employer is required to pay the cost of all substance abuse tests, initial and confirmation, which the employer requires of employees and job applicants.

Additional tests not required by the employer:

• If a job applicant or employee chooses to have an additional test not required by the employer, then the job applicant or employee must pay the cost of any additional test.
• Any additional tests, however, must be conducted on the same specimen as the original test.

Documentation of Reasonable Suspicion Testing:

• If testing is conducted based on reasonable suspicion, the employer shall promptly detail in writing the circumstances which formed the basis of the determination that reasonable suspicion existed to warrant the testing.
• This documentation shall be kept confidential pursuant for at least one year.
• A copy of the above reasonable suspicion documentation should be given to the employee upon request.

Laboratory Responsibilities Required for Certification (OCGA 34-9-415 (e))

____________The laboratory that I am using is complying with the following procedures that are necessary to ensure maximum reliability and accuracy.

NOTE: These standards are required in order to avoid employer and/or laboratory liability for faulty tests results. These standards and procedures are typical of laboratories approved by NIDA/HHS (SAMHSA) or CAP.

Only laboratories that are approved by the National Institute on Drug Abuse (NIDA/HHS) or the College of American Pathologists (CAP) may perform confirmation tests.

Name of laboratory___________________________

Address of laboratory____________________________

Phone number: (______) _______________________

NIDA/HHS (SAMHSA) or CAP Certification: ________________________________

Chain of custody Procedures Required:

• The laboratory must have written procedures to ensure chain of custody.

Quality Control Procedures Required:

• The laboratory must follow proper quality control procedures including, but not limited to [1] the use of internal quality controls including the use of samples of known concentrations which are used to check the performance and calibration of testing equipment, and periodic use of blind samples for overall accuracy; [2] an internal review and certification process for test results, conducted by a person qualified to perform that function in the testing laboratory; [3] security measures implemented by the laboratory to preclude adulteration of specimens and test results; [4] other necessary and proper actions taken to ensure reliable and accurate test results.

Disclosure of Test Results:

• A laboratory must disclose to the employer a written test result report within seven working days after receipt of the sample.
• All laboratory reports of test results shall state at a minimum [1] the name and address of the laboratory that performed the test and positive identification of the person tested; [2] positive results on confirmation tests only; [3] negative results may report from initial or confirmation tests; [4] a list of the drugs for which the analyses were conducted; [5] the type of tests conducted for both initial and confirmation tests and the minimum cut-off levels of the tests.
• No report shall disclose the presence or absence of any drug other than a specific drug and its metabolites listed pursuant to this article.

Technical Assistance Required:

• Laboratories should provide technical assistance to the employer and the employee or job applicant for the purpose of interpreting any positive confirmed tests results which could have been caused by prescription or nonprescription medication.

Confirmation Tests Required for Positive Initial Tests:

• An employer is not obligated to seek a confirmation test on negative initial tests. But if an initial test is negative, the employer may at its sole discretion seek a confirmation test.
• All positive initial tests must be confirmed using the gas chromatography/mass spectrometry (GC/MS) method or an equivalent or more accurate scientifically accepted methods approved by NIDA/HHS (SAMHSA) as such technology becomes available in a cost-effective form.

3. Employee Assistance Required for Certification: (OCGA 34-9-416)

____________EITHER you have an Employee Assistance Program (EAP):

IMPORTANT: See definition of Employee Assistance Program (EAP). A comprehensive EAP provides four of the five components of a certified drug-free workplace program: [1] assistance in policy writing, [2] employee education and awareness, [3] supervisor training, [4] and employee assistance.

The Statute (OCGA 34-9-411(6)) defines Employee Assistance Program as follows:

A. Employee Assistance Program means a worksite focused program designed to assist:

B. A minimum level of core services must include consultation and training and assistance to work organization leadership in policy development, organizational development, and critical incident management; professional, confidential, appropriate, and timely problem assessment services; constructive intervention and short-term problem resolution; referrals for appropriate diagnosis, treatment, and assistance; follow-up, monitoring, and case management with providers and insurers; employee education and supervisory training; and quality assurance.

C. An optimum level of core services must include, in addition to the minimum level core services, the designation of an individual who shall be responsible to administer the employer’s Employee Assistance Program and to certify that the employer work organization’s drug-free workplace program contains all elements of the drug-free workplace program required by Code Section 34-9-413 and that such program satisfies the annual certification requirements of Code Section 34-9-421; provided, however, that such individual shall have training and experience with Employee Assistance Programs in accordance with rules and regulations prescribed by the State Board of Workers’ Compensation.

An EAP is a work-site based service that assists in the identification and resolution of job performance problems associated with employees impaired by personal concerns, including, but not limited to health, marital, family, financial, alcohol, drug, legal, emotional, stress or other problems which may adversely affect employee productivity.

While the function of an EAP is much broader than merely addressing problems associated with substance abuse in the workplace, an EAP does play a significant role in a drug-free workplace program. EAPs are frequently able to identify substance abusing employees before costly problems such as accidents, errors, absenteeism and increased insurance utilization occur. Given the time and money it takes to replace an experienced employee dismissed due to a positive test result, an EAP offers employers an alternative to firing a valued employee found to use drugs.

OR you may maintain and post other means of employee assistance:

Maintenance, distribution, and posting of resource information of providers of other means of employee assistance including drug and alcohol abuse programs, mental health providers, and other persons, entities, or organizations available to assist employees with personal or behavioral problems. (OCGA 34-9-416 (b))

The statute (OCGA 34-9-416) provides that:

Employers must notify employees of the availability of the employer's resource file containing the information on employee assistance and update the resource file during the month of July of each year.

For more information on employee assistance resources in your community, contact the 24-hour Drug Abuse Helpline in Georgia at 1-800-338-6745.

Employers should post this number where employees can see it and distribute this number to employees so as to enable them to access assistance confidentially.

4. Employee Education Required for Certification: (OCGA 34-9-417)

____________Hour One of the Employee Education program has been conducted for employees. (Date of program:______________________)

____________Hour Two of the Employee Education program has been conducted for employees. (Date of program:______________________)

Length of the Employee Education Program:

Content of the Employee Education Program:

• FIRST HOUR CONTENTS of the Employee Education Program must include but is not limited to the following information:

How to communicate the Employee Education Program:

How to document the Employee Education Program:

SECOND AND SUBSEQUENT YEAR CERTIFICATION REQUIRES EMPLOYEE EDUCATION IN THE AMOUNT OF ONE HOUR ANNUALLY.

5. Supervisor Training Required for Certification: (OCGA 34-9-418)

____________Supervisors participated with employees in the above education program,

AND

____________FIRST YEAR REQUIRES two hours of supervisor training on how to recognize signs of substance abuse, how to document and collaborate signs of employee substance abuse, and how to refer substance abusing employees to the proper treatment providers.

• The Supervisor Training Program should include but not be limited to the following information. Employers may choose any of the following topics and even combine them in order to comply with the supervisor training component.

How to communicate the Supervisor Training Program:

How to document the Employee Education Program:

SECOND AND SUBSEQUENT YEARS OF CERTICATION REQUIRES SUPERVISOR TRAINING IN THE AMOUNT OF ONE HOUR ANNUALLY.

6. Confidentiality Required for Certification: (OCGA 34-9-420)

____________All information received through substance abuse testing is confidential, but may be used or received in evidence, or obtained in discovery, or disclosed in any civil or administrative proceeding when the information is relevant to the employer's defense, e.g., a workers' compensation hearing.

The consent form must contain at minimum:

7. Disclaimers regarding a certified drug-free workplace program: (OCGA 34-9-419)

• No physician-patient relationship is created between an employee or job applicant and an employer, MRO, or any person performing or evaluating a substance abuse test solely by the establishment, implementation or administration of substance abuse testing.

• Nothing in the law creating a drug-free workplace program and nothing in this form shall be construed to prevent an employer from establishing reasonable work rules related to employee possession, use, sale, or solicitation of drugs, including convictions for drug-related offenses, and taking action based upon a violation of those rules.

• Nothing in the law or in this form shall be construed to operate retroactively, and nothing in this article shall abrogate the right of an employer under state or federal law to conduct substance abuse tests, or implement employee substance testing.

• Nothing in the law or in this form shall be construed to prohibit an employer from conducting medical screening or other tests required, permitted, or not disallowed by any statute, rule, or regulation for the purpose of monitoring exposure of employees to responsibilities. Such screening or tests shall be limited to the specific materials expressly identified in the statue, rule, or regulation, unless prior written consent of the employee is obtained for other tests.

• No cause of action shall arise in favor of any person based upon the failure of an employer to establish or conduct a program or policy for substance abuse testing.

8. Maintenance and Revocation of Certification:

• Employers must maintain compliance with the criteria for a certified drug-free workplace during the entire year that certification is granted.

• If at any time an insurer has reason to believe that an insured employer with a certified drug-free workplace program has fallen out of compliance, the insurer has the right to physically review and verify the employer's documentation of its certified drug-free workplace program.

• If after reviewing the relevant documentation, the insurer finds that an employer has not maintained its certified drug-free workplace, the insurer should contact the Georgia State Board of Workers' Compensation.

• The State Board will investigate the facts and determine on a case by case basis whether to revoke certification.

• The State Board has the authority to revoke certification if the State Board finds an employer has not substantially complied with the certification requirements.

Definitions applicable to the law, and rules and guidelines:

(1) 'Alcohol' means ethyl alcohol, hydrated oxide of ethyl, or spirits of wine, from whatever source or by whatever process produced.
(2) 'Chain of custody' means the methodology of tracking specified materials, specimens, or substances for the purpose of maintaining control and accountability from initial collection to final disposition for all such materials, specimens, or substances and providing for accountability at each stage in handling, testing, and storing materials, specimens, or substances and reporting test results.
(3) 'Confirmation test', 'confirmed test', and 'confirmed substance abuse test' means a second analytical procedure used to identify the presence of a specific drug or metabolite in a specimen. The confirmation test must be different in scientific principle from that of the initial test procedure. This confirmation method must be capable of providing requisite specificity, sensitivity, and quantitative accuracy. GC/MS is the authorized confirmation test under this statute.
(4) 'Drug' means amphetamines, cannabinoids, cocaine, phencyclidine (PCP), methadone, methaqualene, opiates, barbituates, benzodiazepines, propoxyphene, or a metabolite of any such substances. An employer may test an individual for any or all of these.
(5) 'Employee' means any person who works for salary, wages, or other remuneration for an employer.
(6) 'Employee Assistance Program' means a worksite focused program designed to assist: (i) Employer work organizations in addressing employee productivity issues; and (ii) Employee clients in the identification and resolution of job performance problems associated with employees impaired by personal concerns, including, but not limited to, health, marital, family, financial, alcohol, drug, legal, emotional, stress or other personal issues that may affect job performance. A minimum level of core services must include consultation and training and assistance to work organization leadership in policy development, organizational development, and critical incident management; professional, confidential, appropriate, and timely problem assessment services; constructive intervention and short-term problem resolution; referrals for appropriate diagnosis, treatment, and assistance; follow-up, monitoring, and case management with providers and insurers; employee education and supervisory training; and quality assurance. An optimum level of core services must include, in additional to the minimum level core services, the designation of an individual who shall be responsible to administer the employer’s Employee Assistance Program and to certify that the employer work organization’s drug-free workplace program contains all elements of the drug-free workplace program required by Code Section 34-9-413 and that such program satisfies the annual certification requirements of Code Section 34-9-421; provided, however, that such individual shall have training and experience with Employee Assistance Programs in accordance with rules and regulations prescribed by the State Board of Workers’ Compensation.
(7) 'Employer' means a person or entity that is subject to the provisions of this chapter but shall not include the state or any independent school system or any municipal corporation for the purposes of this chapter.
(8) 'Initial Test' means a sensitive, rapid and reliable procedure to identify negative and presumptive positive specimens including “on-site” testing. All initial tests shall use an immunoassay procedure or an equivalent procedure or shall use a more accurate scientifically accepted method approved by the National Institute on Drug Abuse/HHS or by Georgia law, as such more accurate technology becomes available in a cost-effective form. An employer may also use on-site testing kits for post-offer initial testing of job applicants.
(9) 'Job applicant' means a person who has applied for a position with an employer and has been offered full time employment conditioned upon successfully passing a substance abuse test.
(10) 'Nonprescription medication' means a drug or medication authorized pursuant to federal or state law for general distribution and use without a prescription in the treatment of human disease, ailments, or injuries.
(11) 'Prescription medication' means a drug or medication lawfully prescribed by a physician for an individual and taken in accordance with such prescription.
(12) 'Reasonable suspicion testing' means substance abuse testing based on a belief that an employee is using or has used drugs or alcohol in violation of the employer's policy drawn from specific objective and articulable facts and reasonable inferences drawn from those facts in light of experience. Among other things, such facts and inferences may be based upon, but not limited to the following:

Appendix A

Information on NIDA/HHS (SAMHSA) and CAP laboratories:

NIDA/HHS (SAMHSA) Laboratories:

The federal agency called the National Institute on Drug Abuse (NIDA) has been renamed the Substance Abuse and Mental Health Services Administration (SAMHSA). Laboratories that were certified by NIDA now have certification by SAMHSA under the United States Department of Health and Human Services (HHS).

This name change occurred after the Georgia General Assembly passed the law creating the premium discount for certified drug-free workplaces. The name change does not affect whether a laboratory is certified pursuant to federal minimum standards. If a laboratory used to have NIDA certification, it now has (SAMHSA) HHS certification.

For a list of laboratories which have been certified pursuant to federal minimum standards, please log on to www.drugfreeworkplace.gov. This list is updated monthly. A search by state is available.

CAP Laboratories:

For all information on whether a laboratory has College of American Pathologists (CAP) certification, please log on to www.cap.org, click on Accreditation and Laboratory Improvement, then scroll down to Accredited Laboratory Directory, and then if looking by state, enter that name as the search criterion.

Appendix B

Form documenting completion of Employee Education and Supervisor Training Program.

Fill out this form and attach a list of attendee's signatures to document their participation. Keep this documentation in a file for your review by your insurer or the Georgia State Board of Workers' Compensation Board upon request.

1. Check one:

2. Has employer contracted with an Employee Assistance Program (EAP):
Yes ______________ No _____________

3. Title and Description of Program: _______________________________________________
___________________________________________________________________________
___________________________________________________________________________

4. Length of Program: _________________________________________________

5. Means of communication used to teach the employees and/or supervisors:
___________________________________________________________________________

6. Number of employees/supervisors (circle one): ____________

7. Number of employees/supervisors participating in program (circle one): _____________

8. Signature of trainer or supervisor who conducted this program:

_______________________________ Date: __________________

Appendix C

OVER-THE-COUNTER AND PRESCRIPTION DRUGS THAT MAY ALTER OR AFFECT THE OUTCOME OF A DRUG TEST

*This information is included only to assist employers in evaluating positive test results in relationship to prescription or over the counter drugs reported by employees.
*Please note this list is not exhaustive. In cases of drugs not included on this list, an employer may wish to consult with the laboratory, a MRO, a pharmacist, or other expert for further assistance.

Alcohol
All liquid medications containing ethyl alcohol (ethanol). Please read the label for content. As an example, Vick's Nyquil is 25% (50 proof) ethyl alcohol, Comtrex is 20% (40 proof), Contac Severe Cold Formula Night Strength is 25% (50 proof) and Listerine is 26.9% (54 proof).

Amphetamines
Obetrol, Biphetamine, Desoxyn, dexedrine, Didrex

Cannabinoids
Marinol (Dronabinol, THC)

Cocaine
Cocaine HCI topical solution (Roxanne)

Phenecyclidine
Not legal by prescription.

Methaqualone
Not legal by prescription.

Opiates
Paregoric, Parepectolin, Donnagel PG, Morphine, Tylenol with Codeine, Empirin with Codeine, APAP with Codeine, Aspirin with Codeine, Rubitussin AC Guiatuss AC Novahistine DH, Novahistine Expectorant, Dilaudid (hydromorphone), M-S contin and Roxanol (morphine sulfate), Percodan, Vicodin, etc.

Barbituates
Phenobarbital, Tuinal, Amytal, Nembutal, Seconal, Lotusate, Fioricet, Esgic, Butisol, Mebaral, Butabarbital, Butabital, Phrenilin, Triad, etc.

Benzodiazepines
Ativan, Azene, Clonopin, Dalmane, Diazepam, Librium, Xanax, Serax, Tranxene, Valiumn Verstram, Halcion, Paxipam, Restoril, Centrax.

Methadone
Dolophine, Methadose

Propoxypohene
Darvocet, Darvon N, Dolene, etc.